• Follow us
  • Holding BUMN Farmasi
  • For Healthcare Professional
  • Researcher
  • EN
    Flag IndonesiaID
    Flag EnglishEN
biofarma-logo-bumn biofarma-logo biofarma-logo-131 biofarma-logo-hashtag-only-case
  • Home
  • Who We Are

    About Us
    • Our Focus
    • Our Strategy
    • Our Distribution
    • Our Operations
    • Your Career
    Our Leadership
    • Corporate Executive Team
    • Management Team
    Our Achievement
    • Awards
    • Certification
    Sustainability
    • Our People
    • Access to Vaccine
    • Corporate Social Responsibility
    • Good Corporate Governance
    • Biodiversity
  • Product & Service

    Our Product
    • Combination Vaccine
    • Viral Vaccine
    • Bacterial Vaccine
    • Diagnostic Vaccine
    • Sera
    Our Health Service
    • Service of Industrial Micro Biology
    • Clinical Laboratory Service
    • Vaccination Service
    • Clinic & Pharmacy

    Visit our website

  • Media

    For Media
    • Latest News
    • Current Event
    Vaccine Fact
    Media Release
    FAQ
  • I Want to
search

Good Corporate Governance

In order to build good corporate governance, the Company shall have a commitment, consistent, and persistent from all relevant parties, i.e : all management levels, Employees, Board of Commissioners, Government and other Stakeholders.

  • Good Corporate Governance
  • Quality Assurance Control
  • Responsibilty to Customer
  • Proses Penerapan Tata Kelola Perusahaan
  • Gratification Control Process
  • Process of Whistle Blowing System
  • Guidelines for The Board of Commisioner and Director
  • Biofarma Code of Conduct
  • Guidelines for Handling Conflict of Interest
  • Charter
    • Internal Audit Charter
    • Piagam Komite Audit
    • Piagam Komite Risiko
  • Risk Management
  • Pedoman Direksi
  • Komite Audit
  • Komite Risiko Pengembangan dan GCG
  • Kriteria Penilaian Kinerja Unggul (KPKU)
Select Menu

KOMITMEN & KEBIJAKAN PENERAPAN MANAJEMEN RISIKO

Sebagai wujud komitmen PT Bio Farma (Persero) dalam menerapkan Tata Kelola Perusahaan yang Baik (Good Corporate Governance) yang efektif sesuai dengan Peraturan Menteri BUMN No.1 Tahun 2011 yang mengharuskan BUMN menerapkan manajemen risiko, Perusahaan telah membentuk Divisi Kepatuhan & Manajemen Risiko (Unit Pengelola Manajemen Risiko) yang bertanggung jawab kepada SEPV Legal & Compliance.

 

 

TUJUAN KEBIJAKAN PENERAPAN MANAJEMEN RISIKO

  1. Terwujudnya Komitmen bersama untuk menerapkan Manajemen Risiko;
  2. Tersedianya peraturan dan petunjuk penerapan Manajemen Risiko yang memadai;
  3. Tersedianya dokumen Manajemen Risiko, rencana tindak lanjut, pemantauan (monitoring) dan evaluasi atas tindak lanjut penanganan Risiko;
  4. Terlaksananya Manajemen Risiko yang mendukung sistem pengendalian intern yang efektif;
  5. Terwujudnya peningkatan penerapan Manajemen Risiko secara berkelanjutan (continual improvement);
  6. Meningkatkan kesiapan Perusahaan dalam menghadapi ketidakpastian (uncertainty) yang semakin tinggi serta berpotensi mengancam sumber daya dan bahkan kelangsungan Perusahaan;
  7. Menjaga agar Perusahaan tetap dalam koridor pengelolaan usaha yang berkehati-hatian (prudent operational) dalam setiap aktivitas yang dilakukannya.

 

LINGKUP PENERAPAN MANAJEMEN RISIKO

  1. Setiap Pemilik Risiko (Risk Owner) wajib mengelola Risiko unit kerjanya.

Penerapan Manajemen Risiko sebagai:

 

  1. Kategori Risiko :

  1. STANDAR ACUAN PENERAPAN MANAJEMEN RISIKO (ISO 31000 : 2018)

 

PELAPORAN PENERAPAN MANAJEMEN RISIKO

  1. Laporan Manajemen Risiko

 

 

  1. Laporan Monitoring & Evaluasi Kegiatan Penanganan Risiko

 

RISIKO PERUSAHAAN TAHUN 2020

  • Good Corporate Governance
  • Quality Assurance Control
  • Responsibilty to Customer
  • Proses Penerapan Tata Kelola Perusahaan
  • Gratification Control Process
  • Process of Whistle Blowing System
  • Guidelines for The Board of Commisioner and Director
  • Biofarma Code of Conduct
  • Guidelines for Handling Conflict of Interest
  • Charter
  • Risk Management
  • Pedoman Direksi
  • Komite Audit
  • Komite Risiko Pengembangan dan GCG
  • Kriteria Penilaian Kinerja Unggul (KPKU)

Head Office
Jl. Pasteur No. 28, Bandung 40161,
Jawa Barat Indonesia
No. Telp
+62 22-2033755
Fax
+62 22 - 2041306
Bio Care
1500810
Email
mail@biofarma.co.id
website
www.biofarma.co.id
Digital Healthcare Office Jakarta Lt. 26
Equity Tower Sudirman Central Business District (SCBD) Lot 9
Jl. Jend. Sudirman Kav. 52-53
Jakarta Selatan 12190, Indonesia
Information
  • Good Corporate Governance
  • Our Procurement
  • FAQ
  • Vaccine Production
  • Your Career
 
  • Contact Us
  • E-PPID
  • Announcement
  • I Want to
  • Media Release
Our Partner

Quick Links
  • Portal BUMN-Bio
  • Kemenkes RI
Copyright © 2022. All Rights Reserved by Bio Farma
Holding BUMN Farmasi
For Healthcare Professional
Researcher

Change Language

EN
  • Home
  • Who We Are
    • About Us
      • About Us
      • Our Focus
      • Our Strategy
      • Our Distribution
      • Our Operations
      • Your Career
    • Our Leadership
      • Corporate Executive Team
      • Management Team
    • Our Achievement
      • Awards
      • Certification
    • Sustainability
      • Our People
      • Access to Vaccine
      • Corporate Social Responsibility
      • Good Corporate Governance
      • Biodiversity
  • Product & Service
    • Our Product
      • Our Product
      • Combination Vaccine
      • Viral Vaccine
      • Bacterial Vaccine
      • Diagnostic Vaccine
      • Sera
    • Our Health Service
      • Our Health Service
      • Service of Industrial Micro Biology
      • Clinical Laboratory Service
      • Vaccination Service
      • Clinic & Pharmacy
  • Media
    • For Media
      • For Media
      • Latest News
      • Current Event
    • Vaccine Fact
    • Media Release
    • FAQ
  • I Want to
  • Follow us
Change Language
  • Flag IndonesiaID
  • Flag EnglishEN
BIO CARE 1500810 icon-phone
Youtube icon-youtube
Corporate Reporting icon-statistics